z-logo
Premium
Total vitamin D intake and predictors of circulating 25(OH)D in african american men
Author(s) -
AgursCollins Tanya,
Dodd Kevin,
Williams Erica,
Kittles Rick
Publication year - 2011
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.25.1_supplement.lb209
Subject(s) - medicine , vitamin d and neurology , vitamin , african american , food frequency questionnaire , physiology , endocrinology , gastroenterology , history , ethnology
Purpose Evidence suggests that low vitamin D status is associated with chronic disease including colorectal cancer risk and all‐cause mortality. The purpose of this study was to assess vitamin D status against the new Institute of Medicine (IOM) vitamin D recommendation and to identify predictors of circulating 25(OH)D in 287 healthy African American men. Methods Total vitamin D intake and lifetime ultraviolet light (UV) exposure were measured by questionnaires. Circulating 25(OH)D was measured using serum. Descriptive statistics and linear regression models were used to assess vitamin D intake and explore predictors of circulating 25(OH)D. Results Mean total vitamin D intake (food and supplement) was 272.3 IUs/day (95% CI:245.0,299.6), with only 10% of the sample meeting the 600 IUs recommendation. Mean circulating 25(OH)D was 18.0 ng/ml (95% CI:17.0,19.1), with 35% of the sample who met the recommended 20 ng/ml. A significant predictor of 25(OH)D was total vitamin D intake (food and supplement) p<0.001; lifetime UV exposure was suggestive (p=0.08). We estimated that an increase of 200 IUs from total vitamin D (food and supplement) would increase circulating levels of 25(OH)D by 1.4 ng/ml. Conclusions When compared to the IOM recommendation, circulating vitamin D and intakes were inadequate, which may partially explain increased cancer risk and mortality among African American men.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here